Massive pulmonary embolism-echocardiographic diagnosis and thrombolytic therapy;Massiv lungeemboli-ekkokardiografisk diagnostikk og trombolysebehandling

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 28, 1999, Pages 4194-4198

  Graven, Torbjørn ^a  

^a Kardiologisk Seksjon   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE REPORT; ECHOCARDIOGRAPHY; ECHOGRAPHY; EMERGENCY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; LUNG EMBOLISM; MALE; MIDDLE AGED; PROGNOSIS;

AGED; ECHOCARDIOGRAPHY; EMERGENCIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY;

EID: 0033589401     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Goldhaber SZ, Morpurgo M. Diagnosis, treatment, and prevention of pulmonary embolism. Report of the WHO/International Society and Federation of Cardiology Task Force. JAMA 1992; 268: 1727-33.
2. Diebold J, Lohrs U. Venous thrombosis and pulmonary embolism. A study of 5039 autopsies. Pathol Res Pract 1991; 187: 260-6.
3. Matsumoto AH, Tegtmeyer CJ. Contemporary diagnostic approaches to acute pulmonary emboli. Radiol Clin North Am 1995; 33: 167-83.
4. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975; 17: 257-70.
5. Worsley DF, Alavi A, Aronchick JM, Chen JT, Greenspan RH, Ravin CE. Chest radiographic findings in patients with acute pulmonary embolism: observations from the PIOPED Study. Radiology 1993; 189: 133-6.
6. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). The PIOPED investigators. JAMA 1990; 263: 2753-9.
7. Teigen CL, Maus TP, Sheedy PF, Stanson AW, Johnson CM, Breen JF et al. Pulmonary embolism: diagnosis with contrast-enhanced electron-beam CT and comparison with pulmonary angiography. Radiology 1995; 194: 313-9.
8. Meaney JF, Weg JG, Chenevert TL, Stafford-Johnson D, Hamilton BH, Prince MR. Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 1997; 336: 1422-7.
9. Kinch JW, Ryan TJ. Right ventricular infarction. N Engl J Med 1994; 330: 1211-7.
10. Strauer BE. Physiopathology and clinical aspects of pulmonary embolism. Internist 1984: 25: 108-25.
11. Goldhaber SZ. Contemporary pulmonary embolism thrombolysis. Int J Cardiol 1998; 65 (suppl 1): 91-3.
12. Greenfield LJ, Proctor MC, Williams DM, Wakefield TW. Long-term experience with transvenous catheter pulmonary embolectomy. J Vase Surg 1993; 18: 450-7.
13. Senning A. Left anterior thoracotomy for pulmonary embolectomy with 29-year follow-up. Ann Thorac Surg 1998; 66: 1420-1.
14. Ly B, Arnesen H, Eie H, Hol R. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand 1978; 203: 465-70.
15. Levine M, Hirsh J, Weite J, Cruickshank M, Neemeh J, Turpie AG et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 1990; 98: 1473-9.
16. Jerjes-Sanchez C, Ramirez-Rivera A, Garcia MdL, Arriaga-Nava R, Valencia S, Rosado-Buzzo A et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolys 1995; 2: 227-9.
17. Goldhaber SZ, Kessler CM, Heit JA, Elliott CG, Friedenberg WR, Heiselman DE et al. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol 1992; 20: 24-30.
18. Meneveau N, Schiele F, Metz D, Valette B, Attali P, Vuillemenot A et al. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic out-come and one-year follow-up. J Am Coll Cardiol 1998; 31: 1057-63.
19. Tibbutt DA, Davies JA, Anderson JA, Fletcher EW, Hamill J, Holt JM et al. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. BMJ 1974; 1: 343-7.
20. Goldhaber SZ, Kessler CM, Heit J, Markis J, Sharma GV, Dawley D et al. Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet 1988; 2: 293-8.
21. Meyer G, Sors H, Charbonnier B, Kasper W, Bassand JP, Kerr IH et al. Effects of intravenous urokinase versus alteplase on total pulmonary res-istance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary-Embolism. J Am Coll Cardiol 1992; 19: 239-45.
22. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med 1993; 329: 673-82.
23. Goldhaber SZ. Evolving concepts in thrombolytic therapy for pulmonary embolism. Chest 1992; 101 (suppl 4): 183-5.
24. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988; 2: 349-60.
25. Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith IL et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-11.
26. Verstraete M, Miller GA, Bounameaux H, Charbonnier B, Colle JP, Lecorf G et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988; 77: 353-60.
27. Meneveau N, Schiele F, Vuillemenot A, Valette B, Grollier G, Bernard Y et al. Streptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction. Eur Heart J 1997; 18: 1141-8.
28. Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998; 339: 93-104.
29. Cina G, Pennestri F. Clinical and instru-mental diagnosis of pulmonary embolism. Rays 1996; 21: 340-51.
30. Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 1994; 71: 1-6.
31. Cheriex EC, Sreeram N, Bussen YF, Pieters FA, Wellens HJ. Cross sectional Doppler echocardiography as the initial technique for the diagnosis of acute pulmonary embolism. Br Heart J 1994; 72: 52-7.
32. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J 1995; 130: 1276-82.
33. Jardin F, Dubourg O, Gueret P, Delorme G, Bourdarias JP. Quantitative two-dimensional echocardiography in massive pulmonary embolism: emphasis on ventricular interdependence and leftward septal displacement. J Am Coll Cardiol 1987; 10: 1201-6.
34. McConnell MV, Solomon SD, Rayan ME, Come PC, Goldhaber SZ, Lee RT. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996; 78: 469-73.
35. Nazeyrollas P, Metz D, Chapoutot L, Chabert JP, Maillier B, Maes D et al. Diagnostic accuracy of echocardiography-Doppler in acute pulmonary embolism. Int J Cardiol 1995; 47: 273-80.